(Press-News.org) HIV treatment programs in sub-Saharan Africa should routinely report mortality rates among patients who remain in the programs and those patients lost to follow-up, according to a study by Matthias Egger and colleagues from the International Epidemiologic Databases to Evaluate AIDS in East Africa, Western Africa, and Southern Africa that is published in this week's PLoS Medicine. As a substantial proportion of patients in HIV treatment programs are lost to follow-up, mortality estimates for patients in these programs can be severely underestimated, so this bias needs to be taken into account when comparing the effectiveness of different programs.
The authors arrived at these conclusions by developing a nomogram (calculator) that corrects mortality estimates for loss to follow-up, based on the fact that mortality of all patients starting antiretroviral therapy in an HIV treatment program is a weighted average of mortality among patients lost to follow-up and patients remaining in care.
In an accompanying Perspective, Gregory Bisson from the University of Pennsylvania School of Medicine (not involved in the research) comments that "currently we know little about the biology and behaviors that underlie loss to follow-up, but with 5.2 million people on [antiretroviral therapy], and more starting soon as a result of the 2010 WHO guidelines recommending HIV treatment earlier during disease progression, a greater understanding of loss to follow-up in its various forms is needed in order to keep the HIV treatment effort on track." He adds, "by addressing the effects of loss to follow-up on programmatic mortality estimates, and by providing monitoring efforts with a useful new tool, Egger and colleagues have helped address this need."
INFORMATION:
Funding: This study was supported by the US National Institute of Allergy and Infectious Disease (NIAID, grants U01-AI069924, U01-AI069911, U01-AI069919); Office of AIDS Research of the National Institutes of Health; the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; and the Swiss National Science Foundation. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, et al. (2011) Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa. PLoS Med 8(1): e1000390. doi:10.1371/journal.pmed.1000390
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000390
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-01-egger.pdf
CONTACT:
Matthias Egger
University of Berne
Institute of Social and Preventive Medicine
Finkenhubelweg 11
Bern, Bern 3012
Switzerland
+41 31 631 3501
+41 31 631 3520 (fax)
egger@ispm.unibe.ch
Perspective by Gregory Bisson
Competing Interests: The author has declared that no competing interests exist.
Citation: Bisson GP (2011) A Simple Novel Method for Determining Mortality Rates in HIV Treatment Programs Worldwide. PLoS Med 8(1): e1000392. doi:10.1371/journal.pmed.1000392
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000392
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-01-bisson.pdf
CONTACT:
Gregory P.Bisson
University of Pennsylvania School of Medicine
Department of Medicine and Department of Biostatistics and Epidemiology
832 Blockley Hall
Philadelphia, PA 19104
United States of America
+1 215 573 5811
+1 215 573 5315 (fax)
bisson@mail.med.upenn.edu
A new method to correct mortality rate biases in HIV treatment programs
2011-01-19
ELSE PRESS RELEASES FROM THIS DATE:
Little evidence to support most eHealth technologies, such as electronic patient records
2011-01-19
Despite the wide endorsement of and support for eHealth technologies, such as electronic patient records and e-prescribing, the scientific basis of its benefits—which are repeatedly made and often uncritically accepted—remains to be firmly established.
Furthermore, even for the eHealth technologies that have proven to be successful, there is little evidence to show that such tools would continue to be successful beyond the contexts in which they were originally developed. These are the key findings of a study by Aziz Sheikh (University of Edinburgh, Edinburgh, Scotland) ...
Statins: Benefits questionable in low-risk patients
2011-01-19
There is not enough evidence to recommend the widespread use of statins in people with no previous history of heart disease, according to a new Cochrane Systematic Review. Researchers say statins should be prescribed with caution in those at low risk of cardiovascular disease (CVD).
CVD is the most common cause of death, accounting for nearly a third of all deaths worldwide. Cholesterol-lowering statins are first line treatments for heart patients and the benefits are well established. However, there is less evidence that statins are beneficial for preventing heart problems ...
Drug used to treat heavy periods will stop trauma patients bleeding to death
2011-01-19
Tranexamic acid (TXA), a drug used to treat heavy menstrual periods, could save the lives of tens of thousands of bleeding accident victims each year and reduce combat deaths, say Cochrane researchers. The researchers carried out a systematic review of trials examining the effectiveness of tranexamic acid (TXA) in patients with bleeding after severe injury.
TXA is an inexpensive drug that reduces clot breakdown. It has been used for many years to reduce heavy menstrual bleeding and is often given during planned surgery to reduce the need for blood transfusion. However, ...
Antioxidants may improve chances of conceiving in male subfertility
2011-01-19
Antioxidant supplements may benefit couples who have difficulty conceiving naturally, according to a new systematic review published today in The Cochrane Library. The review provides evidence from a small number of trials that suggest the partners of men who take antioxidants are more likely to become pregnant.
Male subfertility affects one in 20 men. Chemicals called reactive oxygen species (ROS) are said to cause damage to cells, and in particular sperm cells, which may result in lowered sperm counts and interfere with their ability to fertilise eggs. Antioxidants ...
Making health information technology more patient-centered
2011-01-19
RICHMOND, Va. (Jan. 19, 2011) – Personal health records have great potential to help patients manage their health, but technology needs to be designed with the patient in mind – which means doing more than helping patients access health information, according to an editorial by two Virginia Commonwealth University family medicine physicians published in the Jan.19 issue of the Journal of the American Medical Association.
In the editorial, Alexander Krist, M.D., M.P.H., associate professor in the Department of Family Medicine in the VCU School of Medicine, together with ...
Eating more fruit and vegetables is linked to a lower risk of dying from ischemic heart disease
2011-01-19
A European study investigating the links between diet and disease has found that people who consume more fruit and vegetables have a lower risk of dying from ischaemic heart disease – the most common form of heart disease and one of the leading causes of death in Europe. However, the authors point out that a higher fruit and vegetable intake occurs among people with other healthy eating habits and lifestyles, and that these factors could also be associated with the lower risk of dying from IHD. The study is published online today (Wednesday 19 January) in the European Heart ...
Korean researchers reveal new sea defense model
2011-01-19
Los Angeles, CA (January 18, 2010) - Military tension between North Korea and the Republic of Korea (South Korea) extends to areas of the Yellow Sea. Now defence experts based in the Republic of Korea have devised improved methods to model underwater warfare, which they believe can aid future decisions about weapons and defence purchases. The details appear today in the Journal of Defense Modeling and Simulation, published by SAGE.
The researchers based at the Korea Advanced Institute of Science and Technology (KAIST) and Seowon University, both in the Republic of Korea, ...
A different path to fat-related heart disease
2011-01-19
VIDEO:
A team led by Rolf Bodmer, Ph.D., at Sanford-Burnham Medical Research Institute recently unraveled an alternative pathway to lipotoxic cardiomyopathy in fruit flies -- a genetic mechanism that occurs independently...
Click here for more information.
LA JOLLA, Calif., January 18, 2011 – Heart disease is the leading cause of death for both men and women in the United States. But heart disease is more than just one disease; there are many different 'flavors' that can result ...
Weizmann Institute scientists discover: Antioxidants cause fertility problems in females
2011-01-19
Antioxidants are sold over the counter everywhere. They're added to food, drink and face cream. But according to Prof. Nava Dekel of the Biological Regulation Department, we still don't have a complete understanding of how they act in our bodies. New research by Dekel and her team, recently published in the Proceedings of the National Academy of Sciences USA (PNAS), has revealed a possible unexpected side effect of antioxidants: They might cause fertility problems in females.
Common antioxidants include vitamins C and E. These work by eliminating molecules called reactive ...
Scientists identify avoidable breast cancer risk factors
2011-01-19
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
However, neither an individual woman nor medicine can influence whether family members develop breast cancer or at what age menopause starts - these are risk factors on which we have no influence. Scientists of the German Cancer Research Center in the team of Associate Professor (PD) Dr. Karen Steindorf and Professor Dr. ...